Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Aug;33(8):1845-53.
doi: 10.1097/01.ccm.0000171849.04952.79.

Strategies to prevent antimicrobial resistance in the intensive care unit

Affiliations
Review

Strategies to prevent antimicrobial resistance in the intensive care unit

Marin H Kollef et al. Crit Care Med. 2005 Aug.

Abstract

Objective: To assemble the available clinical data for the prevention of antimicrobial resistance into practical recommendations for clinicians.

Data source: A Medline database and references from identified articles were employed to perform a literature search relating to the prevention of antimicrobial resistance.

Conclusions: Antimicrobial resistance has emerged as an important determinant of mortality for patients in the intensive care unit. This is largely due to the increasing presence of pathogenic microorganisms with resistance to existing antimicrobial agents, resulting in the administration of inappropriate treatment. Effective strategies for the prevention of antimicrobial resistance within intensive care units are available and should be aggressively implemented. These strategies can be divided into nonpharmacologic infection control strategies (e.g., routine hand hygiene, implementation of infection-specific prevention protocols) and antibiotic management strategies (e.g., shorter courses of appropriate antibiotic treatment, narrowing of antimicrobial spectrum based on culture results). Increasing current efforts aimed at the prevention of antimicrobial resistance is especially important given the limited availability of new antimicrobial drug classes for the foreseeable future.

PubMed Disclaimer

Substances